Cover Image
市場調查報告書

病毒過濾的全球市場預測 2020年:生技藥品、疫苗 & 治療藥、血液、細胞組織、幹細胞

Virus Filtration Market by Product (Kits & Reagents, Systems, Services), Application (Biologics (Vaccine & Therapeutics, Blood, Tissues, Stem Cells), Devices, Air, Water Purification), End User - Global Forecast to 2020

出版商 MarketsandMarkets 商品編碼 355927
出版日期 內容資訊 英文 186 Pages
訂單完成後即時交付
價格
Back to Top
病毒過濾的全球市場預測 2020年:生技藥品、疫苗 & 治療藥、血液、細胞組織、幹細胞 Virus Filtration Market by Product (Kits & Reagents, Systems, Services), Application (Biologics (Vaccine & Therapeutics, Blood, Tissues, Stem Cells), Devices, Air, Water Purification), End User - Global Forecast to 2020
出版日期: 2016年04月04日 內容資訊: 英文 186 Pages
簡介

全球病毒過濾市場規模,預計從2015到2020年以12.3%的年複合成長率發展,從2015年的18億2,000萬美元到2020年擴大到32億5,000萬美元。該市場的成長主要由於R&D費用的上升,生物醫藥品產業的成長,及醫藥品、生物科技產業的政府支援的高漲而受促進。還有病毒過濾市場上最新趨勢,是一次性使用技術引進的高漲。

本報告提供全球病毒過濾市場相關調查,市場概要,產業結構與價值鏈,對市場成長的各種影響因素與市場機會分析,各產品、用途、終端用戶,及地區/主要國家等趨勢與市場規模的變化與預測,競爭環境,以及主要企業的簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 病毒過濾市場概要
  • 生命週期分析:各地區

第5章 市場概要

  • 簡介
    • 各產品
    • 各用途
    • 各終端用戶
  • 市場動態
    • 成長推進因素
    • 阻礙成長要素
    • 機會
    • 課題

第6章 病毒過濾市場:各產品

  • 簡介
  • 套件、試劑
  • 過濾系統
  • 服務
  • 其他的產品

第7章 病毒過濾市場:各用途

  • 簡介
  • 生技藥品
    • 疫苗、治療藥
    • 血液、血液製劑
    • 細胞療法、遺傳基因療法產品
    • 細胞組織、細胞組織產品
    • 幹細胞產品
  • 醫療設備
  • 水質淨化
  • 空氣清淨

第8章 病毒過濾市場:各終端用戶

  • 簡介
  • 醫藥品 & 生物科技企業
  • CRO (醫藥品臨床研究委外機構)
  • 大學研究機關
  • 醫療設備企業

第9章 病毒過濾市場:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
  • 亞洲
    • 中國
    • 日本
    • 印度
    • 其他亞洲
  • 其他地區 (ROW)

第10章 競爭環境

  • 簡介
  • 策略概要
  • 市場佔有率分析
  • 競爭情形、趨勢

第11章 企業簡介 (概要、財務、產品與服務、策略、發展趨勢)

  • 簡介
  • MERCK KGAA
  • GENERAL ELECTRIC COMPANY
  • THERMO FISHER SCIENTIFIC, INC.
  • LONZA GROUP LTD.
  • PALL CORPORATION
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
  • SIGMA-ALDRICH CORPORATION
  • SARTORIUS AG
  • 旭化成醫學
  • WUXI PHARMATECH (CAYMAN) INC.

第12章 附錄

圖表

目錄
Product Code: BT 4204

The global virus filtration market is projected to reach USD 3.25 billion by 2020 from USD 1.82 billion in 2015, at a CAGR of 12.3% between 2015 and 2020. By product, the market includes kits and reagents, filtration systems, other products and services. Based on application segment includes biologicals, medical devices, water purification, and air purification. The biologicals segment is further classified into, vaccines and therapeutics, blood and blood products, cellular and gene therapy products, tissue and tissue products and stem cell products.

The end user segments included in this report are pharmaceutical & biotechnology companies, contract research organizations, academic research institutes and medical devices companies. The pharmaceutical & biotechnology companies segment is expected to hold the largest share of the virus filtration market in 2015.

The geographic segments included in this report are North America, Europe, Asia, and Rest of the World (RoW). North America is expected to account for the largest share in the global the virus filtration market in 2015. Asia is expected to register the fastest growth during the forecast period.

The growth of this market is mainly driven by the rise in R&D expenditure, growth of biopharmaceutical industry, and increasing government support for pharmaceutical and biotechnology industry are driving factors of the virus filtration market. In addition, increasing adoption of single-use technologies is the latest trend observed in the virus filtration market.

A combination of bottom-up and top-down approaches were used to calculate the market sizes and growth rates of the global virus filtration market and its sub-segments. All percentage shares, splits, and breakdowns for market segments were determined using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in this research study have been considered, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each sub segment and the relative differences in growth rates. The report provides qualitative insights about growth rates, and market drivers for all sub segments. It maps market sizes and growth rates for each sub segment and identifies segments poised for rapid growth in each geographic segment. The report also includes company profiles of market leaders such as

Merck & Co., Inc. (U.S.), General Electric Company (U.S.), Thermo Fisher Scientific Inc. (U.S.), Lonza Group Ltd. (Switzerland), and Pall Corporation (U.S.), Charles River Laboratories International, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), Sartorius AG (Germany), Asahi Kasei Medical Co., Ltd. (Japan) and WuXi PharmaTech (Cayman) Inc. (China).

Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and to help them make important strategic growth decisions.

The report provides insights on the following:

  • Product Development/Innovation: Product portfolios of the top players in the virus filtration market. Detailed insights on upcoming technologies, research and development activities, and new product launches in the insights on upcoming technologies market
  • Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of the leading players in the virus filtration market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various virus filtration across geographies
  • Market Diversification: Exhaustive information about new products, recent developments, and investments in the virus filtration market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.3. MARKET SHARE ESTIMATION
    • 2.3.1. KEY DATA FROM SECONDARY SOURCES
    • 2.3.2. KEY DATA FROM PRIMARY SOURCES
  • 2.4. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. VIRUS FILTRATION MARKET OVERVIEW
  • 4.2. LIFE CYCLE ANALYSIS, BY REGION

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
    • 5.1.1. BY PRODUCT
    • 5.1.2. BY APPLICATION
    • 5.1.3. BY END USER
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Increasing R&D spending
      • 5.2.1.2. Growth in biopharmaceutical industry
      • 5.2.1.3. Increasing government support for the pharmaceutical & biotechnology industry
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Stringent regulations for validation of filtration products
      • 5.2.2.2. Highly consolidated market
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Asia presents high-growth opportunities
      • 5.2.3.2. Increasing pharmaceutical outsourcing
    • 5.2.4. TREND
      • 5.2.4.1. Rising adoption of single-use technologies

6. VIRUS FILTRATION MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. KITS AND REAGENTS
  • 6.3. FILTRATION SYSTEMS
  • 6.4. SERVICES
  • 6.5. OTHER PRODUCTS

7. VIRUS FILTRATION MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. BIOLOGICALS
    • 7.2.1. VACCINES AND THERAPEUTICS
    • 7.2.2. BLOOD AND BLOOD PRODUCTS
    • 7.2.3. CELLULAR AND GENE THERAPY PRODUCTS
    • 7.2.4. TISSUE AND TISSUE PRODUCTS
    • 7.2.5. STEM CELL PRODUCTS
  • 7.3. MEDICAL DEVICES
  • 7.4. WATER PURIFICATION
  • 7.5. AIR PURIFICATION

8. VIRUS FILTRATION MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 8.3. CONTRACT RESEARCH ORGANIZATIONS
  • 8.4. ACADEMIC RESEARCH INSTITUTES
  • 8.5. MEDICAL DEVICE COMPANIES

9. VIRUS FILTRATION MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. U.S.
    • 9.2.2. CANADA
  • 9.3. EUROPE
  • 9.4. ASIA
    • 9.4.1. CHINA
    • 9.4.2. JAPAN
    • 9.4.3. INDIA
    • 9.4.4. REST OF ASIA (ROA)
  • 9.5. REST OF THE WORLD (ROW)

10. COMPETITIVE LANDSCAPE

  • 10.1. INTRODUCTION
  • 10.2. STRATEGIC OVERVIEW
  • 10.3. MARKET SHARE ANALYSIS
  • 10.4. COMPETITIVE SITUATION AND TRENDS
    • 10.4.1. NEW PRODUCT LAUNCHES AND UPGRADES
    • 10.4.2. AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
    • 10.4.3. MERGERS & ACQUISITIONS
    • 10.4.4. EXPANSIONS

11. COMPANY PROFILES (Overview, Financials, Products & Services, Strategy, & Developments)*

  • 11.1. INTRODUCTION
  • 11.2. MERCK KGAA
  • 11.3. GENERAL ELECTRIC COMPANY
  • 11.4. THERMO FISHER SCIENTIFIC, INC.
  • 11.5. LONZA GROUP LTD.
  • 11.6. PALL CORPORATION
  • 11.7. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
  • 11.8. SIGMA-ALDRICH CORPORATION
  • 11.9. SARTORIUS AG
  • 11.10. ASAHI KASEI MEDICAL CO., LTD.
  • 11.11. WUXI PHARMATECH (CAYMAN) INC.

*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. INSIGHTS OF INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. OTHER DEVELOPMENTS
  • 12.4. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.5. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.6. AVAILABLE CUSTOMIZATIONS
  • 12.7. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: VIRUS FILTRATION MARKET SUMMARY
  • TABLE 2: INCREASING R&D SPENDING: THE PRIMARY GROWTH DRIVER FOR THE VIRUS FILTRATION MARKET
  • TABLE 3: STRINGENT REGULATORY POLICIES FOR VALIDATION OF FILTRATION PRODUCTS TO RESTRICT MARKET GROWTH
  • TABLE 4: ASIA PRESENTS HIGH-GROWTH OPPORTUNITIES IN THE VIRUS FILTRATION MARKET
  • TABLE 5: SINGLE-USE TECHNOLOGIES IS A MAJOR TREND OBSERVED IN THE VIRUS FILTRATION MARKET
  • TABLE 6: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 7: VIRUS FILTRATION KITS AND REAGENTS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 8: VIRUS FILTRATION SYSTEMS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 9: VIRUS FILTRATION SERVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 10: OTHER VIRUS FILTRATION PRODUCTS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 11: VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 12: VIRUS FILTRATION MARKET SIZE FOR BIOLOGICALS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 13: VIRUS FILTRATION MARKET SIZE FOR BIOLOGICALS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 14: VIRUS FILTRATION MARKET SIZE FOR VACCINES AND THERAPEUTICS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 15: VIRUS FILTRATION MARKET SIZE FOR BLOOD AND BLOOD PRODUCTS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 16: VIRUS FILTRATION MARKET SIZE FOR CELLULAR AND GENE THERAPY PRODUCTS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 17: VIRUS FILTRATION MARKET SIZE FOR TISSUE AND TISSUE PRODUCTS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 18: VIRUS FILTRATION MARKET SIZE FOR STEM CELL PRODUCTS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 19: VIRUS FILTRATION MARKET SIZE FOR MEDICAL DEVICES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 20: VIRUS FILTRATION MARKET SIZE FOR WATER PURIFICATION APPLICATIONS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 21: VIRUS FILTRATION MARKET SIZE FOR AIR PURIFICATION APPLICATIONS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 22: VIRUS FILTRATION MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 23: VIRUS FILTRATION MARKET SIZE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 24: VIRUS FILTRATION MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 25: VIRUS FILTRATION MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 26: VIRUS FILTRATION MARKET SIZE FOR MEDICAL DEVICE COMPANIES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 27: VIRUS FILTRATION MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 28: NORTH AMERICA: VIRUS FILTRATION MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 29: NORTH AMERICA: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 30: NORTH AMERICA: VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 31: NORTH AMERICA: VIRUS FILTRATION BIOLOGICALS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 32: NORTH AMERICA: VIRUS FILTRATION MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 33: U.S.: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 34: U.S.: VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 35: U.S.: VIRUS FILTRATION BIOLOGICALS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 36: U.S.: VIRUS FILTRATION MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 37: CANADA: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 38: CANADA: VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 39: CANADA: VIRUS FILTRATION BIOLOGICALS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 40: CANADA: VIRUS FILTRATION MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 41: EUROPE: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 42: EUROPE: VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 43: EUROPE: VIRUS FILTRATION BIOLOGICALS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 44: EUROPE: VIRUS FILTRATION MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 45: ASIA: VIRUS FILTRATION MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 46: ASIA: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 47: ASIA: VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 48: ASIA: VIRUS FILTRATION MARKET SIZE FOR BIOLOGICALS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 49: ASIA: VIRUS FILTRATION MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 50: CHINA: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 51: CHINA: VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 52: CHINA: VIRUS FILTRATION MARKET SIZE FOR BIOLOGICALS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 53: CHINA: VIRUS FILTRATION MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 54: JAPAN: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 55: JAPAN: VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 56: JAPAN: VIRUS FILTRATION MARKET SIZE FOR BIOLOGICALS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 57: JAPAN: VIRUS FILTRATION MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 58: INDIA: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 59: INDIA: VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 60: INDIA: VIRUS FILTRATION MARKET SIZE FOR BIOLOGICALS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 61: INDIA: VIRUS FILTRATION MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 62: ROA: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 63: ROA: VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 64: ROA: VIRUS FILTRATION MARKET SIZE FOR BIOLOGICALS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 65: ROA: VIRUS FILTRATION MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 66: ROW: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 67: ROW: VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 68: ROW: VIRUS FILTRATION MARKET SIZE FOR BIOLOGICALS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 69: ROW: VIRUS FILTRATION MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 70: MARKET DEVELOPMENTS BETWEEN JANUARY 2013 AND MARCH 2016
  • TABLE 71: NEW PRODUCT LAUNCHES AND UPGRADES, 2013-2016
  • TABLE 72: AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, 2013-2016
  • TABLE 73: MERGERS & ACQUISITIONS, 2013-2016
  • TABLE 74: EXPANSIONS, 2013-2016

LIST OF FIGURES

  • FIGURE 1: GLOBAL VIRUS FILTRATION MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 5: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2015 VS. 2020 (USD MILLION)
  • FIGURE 8: VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2015 VS. 2020 (USD MILLION)
  • FIGURE 9: BIOLOGICALS MARKET SIZE, BY TYPE, 2015 VS. 2020 (USD MILLION)
  • FIGURE 10: VIRUS FILTRATION MARKET SIZE, BY END USER, 2015 VS. 2020 (USD MILLION)
  • FIGURE 11: VIRUS FILTRATION MARKET SIZE, BY REGION, 2015 VS. 2020 (USD MILLION)
  • FIGURE 12: GLOBAL VIRUS FILTRATION MARKET TO WITNESS MODERATE GROWTH DURING THE FORECAST PERIOD
  • FIGURE 13: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT TO DOMINATE THE VIRUS FILTRATION MARKET IN 2015
  • FIGURE 14: ASIA TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 15: ASIAN MARKET SHOWCASES LUCRATIVE GROWTH OPPORTUNITIES
  • FIGURE 16: VIRUS FILTRATION MARKET SEGMENTATION: BY PRODUCT
  • FIGURE 17: VIRUS FILTRATION MARKET SEGMENTATION: BY APPLICATION
  • FIGURE 18: VIRUS FILTRATION MARKET SEGMENTATION: BY END USER
  • FIGURE 19: INCREASING R&D SPENDING WILL DRIVE THE VIRUS FILTRATION MARKET DURING THE FORECAST PERIOD
  • FIGURE 20: GLOBAL PHARMACEUTICAL R&D SPENDING (2001-2011)
  • FIGURE 21: VIRUS FILTRATION MARKET SEGMENTATION, BY PRODUCT
  • FIGURE 22: KITS AND REAGENTS TO FORM THE LARGEST PRODUCT SEGMENT IN 2015
  • FIGURE 23: NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION KITS AND REAGENTS MARKET IN 2015
  • FIGURE 24: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE VIRUS FILTRATION SYSTEMS MARKET IN 2015
  • FIGURE 25: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF VIRUS FILTRATION SERVICES MARKET IN 2015
  • FIGURE 26: NORTH AMERICA TO DOMINATE THE OTHER VIRUS FILTRATION PRODUCTS MARKET IN 2015
  • FIGURE 27: VIRUS FILTRATION MARKET SEGMENTATION, BY APPLICATION
  • FIGURE 28: BIOLOGICALS TO DOMINATE THE VIRUS FILTRATION APPLICATIONS MARKET IN 2015
  • FIGURE 29: VACCINES AND THERAPEUTICS TO DOMINATE THE VIRUS FILTRATION MARKET FOR BIOLOGICALS IN 2015
  • FIGURE 30: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE VIRUS FILTRATION MARKET FOR BIOLOGICALS IN 2015
  • FIGURE 31: NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR VACCINES AND THERAPEUTICS IN 2015
  • FIGURE 32: NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR BLOOD AND BLOOD PRODUCTS IN 2015
  • FIGURE 33: NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR CELLULAR AND GENE THERAPY PRODUCTS IN 2015
  • FIGURE 34: NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR TISSUE AND TISSUE PRODUCTS IN 2015
  • FIGURE 35: NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR STEM CELL PRODUCTS IN 2015
  • FIGURE 36: NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR MEDICAL DEVICES IN 2015
  • FIGURE 37: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE VIRUS FILTRATION MARKET FOR WATER PURIFICATION APPLICATIONS IN 2015
  • FIGURE 38: NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR AIR PURIFICATION APPLICATIONS IN 2015
  • FIGURE 39: VIRUS FILTRATION MARKET SEGMENTATION, BY END USER
  • FIGURE 40: VIRUS FILTRATION MARKET SIZE, BY END USER, 2015 (USD MILLION)
  • FIGURE 41: PATENTS FILED: GLOBAL DISTRIBUTION IN 2012
  • FIGURE 42: NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN 2015
  • FIGURE 43: NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS BETWEEN 2015 AND 2020
  • FIGURE 44: ASIA TO WITNESS HIGHEST GROWTH IN THE VIRUS FILTRATION MARKET FOR ACADEMIC RESEARCH INSTITUTES
  • FIGURE 45: NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR MEDICAL DEVICE COMPANIES BETWEEN 2015 AND 2020
  • FIGURE 46: VIRUS FILTRATION MARKET, BY REGION (MARKET SIZE AND GROWTH RATE), 2015-2020
  • FIGURE 47: VIRUS FILTRATION MARKET IN ASIA TO GROW AT THE HIGHEST RATE (2015 TO 2020)
  • FIGURE 48: NORTH AMERICA: VIRUS FILTRATION MARKET SNAPSHOT
  • FIGURE 49: U.S. TO DOMINATE THE NORTH AMERICAN VIRUS FILTRATION MARKET IN 2015
  • FIGURE 50: KITS & REAGENTS ESTIMATED TO FORM THE LARGEST PRODUCT SEGMENT IN THE NORTH AMERICAN VIRUS FILTRATION MARKET IN 2015
  • FIGURE 51: BIOLOGICALS TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICAN VIRUS FILTRATION MARKET IN 2015
  • FIGURE 52: VACCINES & THERAPEUTICS ESTIMATED TO FORM THE LARGEST SEGMENT IN THE NORTH AMERICAN BIOLOGICALS MARKET IN 2015
  • FIGURE 53: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR THE LARGEST SHARE OF THE VIRUS FILTRATION END-USER MARKET IN NORTH AMERICA
  • FIGURE 54: KITS & REAGENTS ESTIMATED TO FORM THE LARGEST PRODUCT SEGMENT IN THE U.S. VIRUS FILTRATION MARKET IN 2015
  • FIGURE 55: BIOLOGICALS APPLICATION SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE U.S. VIRUS FILTRATION MARKET IN 2015
  • FIGURE 56: VACCINES & THERAPEUTICS ESTIMATED TO FORM THE LARGEST SEGMENT IN THE U.S. VIRUS FILTRATION BIOLOGICALS MARKET IN 2015
  • FIGURE 57: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR THE LARGEST SHARE OF THE VIRUS FILTRATION END-USER MARKET IN THE U.S.
  • FIGURE 58: KITS & REAGENTS TO DOMINATE THE VIRUS FILTRATION PRODUCTS MARKET IN CANADA IN 2015
  • FIGURE 59: BIOLOGICALS TO ACCOUNT FOR THE LARGEST OF THE VIRUS FILTRATION APPLICATIONS MARKET IN CANADA IN 2015
  • FIGURE 60: KITS & REAGENTS TO FORM THE LARGEST PRODUCT SEGMENT OF VIRUS FILTRATION BIOLOGICALS MARKET IN CANADA
  • FIGURE 61: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE THE VIRUS FILTRATION END-USER MARKET IN CANADA
  • FIGURE 62: KITS & REAGENTS TO FORM THE LARGEST PRODUCT SEGMENT IN THE EUROPEAN VIRUS FILTRATION MARKET IN 2015
  • FIGURE 63: BIOLOGICALS TO COMMAND THE LARGEST SHARE OF THE VIRUS FILTRATION APPLICATIONS MARKET IN EUROPE IN 2015
  • FIGURE 64: VACCINES AND THERAPEUTICS TO FORM THE LARGEST SEGMENT IN THE VIRUS FILTRATION BIOLOGICALS MARKET IN EUROPE
  • FIGURE 65: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO COMMAND THE LARGEST SHARE OF THE VIRUS FILTRATION END-USER MARKET IN EUROPE
  • FIGURE 66: ASIAN VIRUS FILTRATION MARKET SNAPSHOT
  • FIGURE 67: CHINA ESTIMATED TO DOMINATE THE ASIAN VIRUS FILTRATION MARKET IN 2015
  • FIGURE 68: KITS AND REAGENTS TO FORM THE LARGEST PRODUCT SEGMENT IN THE ASIAN MARKET IN 2015
  • FIGURE 69: BIOLOGICALS TO ACCOUNT FOR THE LARGEST SHARE OF THE VIRUS FILTRATION APPLICATION MARKET IN ASIA IN 2015
  • FIGURE 70: VACCINES AND THERAPEUTICS TO DOMINATE THE ASIAN VIRUS FILTRATION MARKET FOR BIOLOGICALS IN 2015
  • FIGURE 71: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE THE VIRUS FILTRATION END-USER MARKET IN ASIA
  • FIGURE 72: KITS AND REAGENTS TO FORM THE LARGEST PRODUCT SEGMENT IN THE VIRUS FILTRATION MARKET IN CHINA IN 2015
  • FIGURE 73: BIOLOGICALS TO DOMINATE THE VIRUS FILTRATION APPLICATIONS MARKET IN CHINA IN 2015
  • FIGURE 74: VACCINES AND THERAPEUTICS TO DOMINATE THE VIRUS FILTRATION MARKET FOR BIOLOGICALS IN CHINA IN 2015
  • FIGURE 75: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE THE VIRUS FILTRATION END-USER MARKET IN CHINA
  • FIGURE 76: KITS AND REAGENTS TO DOMINATE THE VIRUS FILTRATION PRODUCTS MARKET IN JAPAN IN 2015
  • FIGURE 77: BIOLOGICALS TO DOMINATE THE VIRUS FILTRATION APPLICATION MARKET IN JAPAN IN 2015
  • FIGURE 78: VACCINES AND THERAPEUTICS TO DOMINATE THE VIRUS FILTRATION MARKET FOR BIOLOGICALS IN JAPAN IN 2015
  • FIGURE 79: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE THE VIRUS FILTRATION END-USER MARKET IN JAPAN
  • FIGURE 80: KITS AND REAGENTS TO DOMINATE THE VIRUS FILTRATION PRODUCTS MARKET IN INDIA IN 2015
  • FIGURE 81: BIOLOGICALS TO DOMINATE THE VIRUS FILTRATION APPLICATION MARKET IN INDIA IN 2015
  • FIGURE 82: VACCINES AND THERAPEUTICS TO DOMINATE THE VIRUS FILTRATION MARKET FOR BIOLOGICALS IN INDIA IN 2015
  • FIGURE 83: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE THE VIRUS FILTRATION END-USER MARKET IN INDIA
  • FIGURE 84: KITS AND REAGENTS ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE VIRUS FILTRATION MARKET IN ROA IN 2015
  • FIGURE 85: BIOLOGICALS TO DOMINATE THE VIRUS FILTRATION APPLICATION MARKET IN ROA IN 2015
  • FIGURE 86: VACCINES AND THERAPEUTICS TO DOMINATE THE VIRUS FILTRATION MARKET FOR BIOLOGICALS IN ROA IN 2015
  • FIGURE 87: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR THE LARGEST SHARE OF THE VIRUS FILTRATION END-USER MARKET IN ROA
  • FIGURE 88: KITS AND REAGENTS ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE ROW VIRUS FILTRATION MARKET IN 2015
  • FIGURE 89: BIOLOGICALS TO ACCOUNT FOR THE LARGEST SHARE OF THE ROW VIRUS FILTRATION APPLICATION MARKET IN 2015
  • FIGURE 90: VACCINES AND THERAPEUTICS ESTIMATED TO DOMINATE THE VIRUS FILTRATION MARKET FOR BIOLOGICALS IN ROW IN 2015
  • FIGURE 91: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR THE LARGEST SHARE OF THE ROW VIRUS FILTRATION END-USER MARKET
  • FIGURE 92: NEW PRODUCT LAUNCHES AND UPGRADES WAS THE KEY STRATEGY ADOPTED BY PLAYERS IN THE VIRUS FILTRATION MARKET
  • FIGURE 93: VIRUS FILTRATION MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014
  • FIGURE 94: FINANCIAL PERFORMANCES OF THE LEADING MARKET PLAYERS
  • FIGURE 95: COMPANY SNAPSHOT: MERCK & CO., INC.
  • FIGURE 96: COMPANY SNAPSHOT: GENERAL ELECTRIC COMPANY
  • FIGURE 97: COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC, INC.
  • FIGURE 98: COMPANY SNAPSHOT: LONZA GROUP LTD.
  • FIGURE 99: COMPANY SNAPSHOT: PALL CORPORATION
  • FIGURE 100: COMPANY SNAPSHOT: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
  • FIGURE 101: COMPANY SNAPSHOT: SIGMA-ALDRICH CORPORATION
  • FIGURE 102: COMPANY SNAPSHOT: SARTORIUS AG
  • FIGURE 103: COMPANY SNAPSHOT: ASAHI KASEI MEDICAL CO., LTD.
  • FIGURE 104: COMPANY SNAPSHOT: WUXI PHARMATECH (CAYMAN) INC.
Back to Top